Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BENDAMUSTINE for B-cell small lymphocytic lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 94 adverse event reports in the FDA FAERS database where BENDAMUSTINE was used for B-cell small lymphocytic lymphoma.

Most Reported Side Effects for BENDAMUSTINE

Side Effect Reports % Deaths Hosp.
Off label use 2,578 13.1% 532 730
Disease progression 2,456 12.5% 587 332
Pyrexia 1,322 6.7% 193 875
Neutropenia 1,256 6.4% 249 444
Drug ineffective 1,135 5.8% 290 302
Febrile neutropenia 1,005 5.1% 228 627
Pneumonia 975 5.0% 384 623
Thrombocytopenia 967 4.9% 214 351
Covid-19 892 4.5% 268 421
Anaemia 817 4.2% 186 328
Death 800 4.1% 800 151
Product use in unapproved indication 715 3.6% 189 264
Malignant neoplasm progression 664 3.4% 221 153
Pancytopenia 605 3.1% 187 284
Diarrhoea 588 3.0% 118 322

Other Indications for BENDAMUSTINE

Diffuse large b-cell lymphoma (3,538) Chronic lymphocytic leukaemia (2,561) Product used for unknown indication (1,678) B-cell lymphoma (1,668) Follicular lymphoma (1,560) Mantle cell lymphoma (1,227) Non-hodgkin's lymphoma (987) Plasma cell myeloma (945) Hodgkin's disease (676) Lymphoma (612)

Other Drugs Used for B-cell small lymphocytic lymphoma

IBRUTINIB (1,882) VENETOCLAX (499) RITUXIMAB (248) ACALABRUTINIB (151) CYCLOPHOSPHAMIDE (107) LENALIDOMIDE (103) ZANUBRUTINIB (74) VINCRISTINE (68) IDELALISIB (65) PREDNISONE (60)

Related Pages

BENDAMUSTINE Full Profile All B-cell small lymphocytic lymphoma Drugs BENDAMUSTINE Demographics BENDAMUSTINE Timeline